Nexus AG
XETRA:NXU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Nexus AG
Operating Income
Nexus AG
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Nexus AG
XETRA:NXU
|
Operating Income
€43.2m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
CompuGroup Medical SE & Co KgaA
XETRA:COP
|
Operating Income
€93.9m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
5%
|
|
|
Mevis Medical Solutions AG
XETRA:M3V
|
Operating Income
€2.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-6%
|
|
|
DocCheck AG
XETRA:AJ91
|
Operating Income
€6.8m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
CHAPTERS Group AG
XETRA:CHG
|
Operating Income
-€29.1m
|
CAGR 3-Years
-464%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Nexus AG
Glance View
Nexus AG, a prominent figure in the healthcare IT sector, has carved a niche for itself by specializing in software solutions that enhance the operational efficiency and care quality of hospitals and healthcare institutions. Founded with a vision to bridge the gap between innovative technology and healthcare services, Nexus AG crafts integrated software platforms that streamline hospital workflows, from patient admission to billing processes. This not only helps healthcare providers improve service delivery but also allows for smoother regulatory compliance and administrative management. By understanding the unique challenges faced by healthcare professionals, Nexus AG has positioned itself as an indispensable partner to over a thousand hospitals across Europe and beyond. The revenue model of Nexus AG hinges on the strategic deployment of its software solutions, combining upfront licensing fees with ongoing maintenance and support contracts. This ensures a steady stream of recurring revenue, bolstered by consultancy services and tailored modifications that meet client-specific needs. The company continuously invests in research and development to keep its offerings cutting-edge, while also exploring expansion opportunities in adjacent markets and technologies. By fostering long-term relationships with its clients, Nexus AG transforms technological advancement into tangible solutions that provide efficiency and cost savings for the healthcare sector, sustaining its growth and relevance in an ever-evolving market.
See Also
What is Nexus AG's Operating Income?
Operating Income
43.2m
EUR
Based on the financial report for Sep 30, 2025, Nexus AG's Operating Income amounts to 43.2m EUR.
What is Nexus AG's Operating Income growth rate?
Operating Income CAGR 10Y
17%
Over the last year, the Operating Income growth was 16%. The average annual Operating Income growth rates for Nexus AG have been 16% over the past three years , 18% over the past five years , and 17% over the past ten years .